Error - something went wrong!
Moving to value-based arrangements for high-dollar and high-variation specialties like oncology is often co...
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and lasting impact of COVID
In this video update from SOMOS Community Care, Dr. Ramon Tallaj discusses the move from crisis to recovery.
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
This second update from SOMOS, a network of 2,500 New York City primary care physicians, highlights new lessons learned to help move the nation from crisis to recovery.
This on-demand webinar from a network of 2,500 New York City primary care physicians shares best practices for responding to COVID-19 infections in some of the nation’s most vulnerable communities.
Moving to value-based arrangements for high-dollar and high-variation specialties like oncology is often complicated by the complexity of care, an unpredictable pipeline of innovation, and surging dru
Hear firsthand from Cancer Care Specialists of Illinois (CCSI), a community-based oncology practice, about achieving success in the OCM program and how they are leveraging New Century Health’s risk mi
Population health is a central component of value-based care. However, despite significant investment, the ability to generate value varies greatly from one organization to the next. Why is this?
Hear from risk adjustment experts on the best practices you can implement to minimize execution risk and engage your entire physician network in your program
Dr. James Porter, CMO of Deaconess Health System and Evolent's Chris Dawe discuss why Deaconess joined the NextGen ACO program, what they learned, and why their partnership with Evolent is essential.
Our experts help you determine solutions with physicians, for physicians, to ensure success for all stakeholders in Risk Adjustment.
Provider-Sponsored Health Plans have long been viewed as the ultimate endpoint for value-based health care models, and the looming question is no longer “when” to launch a PSHP, but “how”?
Leverage Evolent's experience as an operational partner to multiple Next Gen participants and learn the keys to succeeding in the Next Gen ACO program.